増殖 (JP Patent Analysis Report)
The Technical Field "増殖" had 843 patent application filings in the most recent period (2022-01-01 to 2022-09-30). This is a significantly decreased of -503 filings (-37.4%) over 1,346 they had in the same period of the previous year (2021-01-01 to 2021-09-30).
The highest number of filings in 2016 with 2,756 cases, and their lowest number in 2022 with 896 cases.
The mean of the number of filings over the last 5 years (2018 to 2023, 9,454 cases in total) is 1,576, and the median is 1,905. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
| Index | Value |
|---|---|
| Average | 1,576 patents |
| Std Dev | 845 |
| COV | 0.5 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 896 cases | -50.2 % |
| 2021 year | 1,800 cases | -10.45 % |
| 2020 year | 2,010 cases | -11.41 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for 増殖 for the period of the last 10 years (2014-01-01 to 2024-05-31). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of 増殖, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
増殖, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of 増殖 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 19,716 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
増殖
Related Patent Analysis Report
A patent aanlysis report on the following synonyms was found in the technical term "増殖".
- 増殖 (Main page / Including the following synonyms)
Same industry / competition company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 増殖 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2022 to 2024).
Comparing the number of applications of each company, ジェネンテックインコーポレイテッド has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 14 cases, followed by ザリージェンツオブザユニバーシティオブカリフォルニア with 9 cases.
| Name | Cases |
|---|---|
| ジェネンテックインコーポレイテッド | 14 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 9 cases |
| ブリストル-マイヤーズスクイブカンパニー | 6 cases |
| ノバルティスアーゲー | 4 cases |
| 株式会社東芝 | 1 cases |
| 株式会社日立製作所 | 1 cases |
| メルクパテントゲゼルシャフトミットベシュレンクテルハフツング | 1 cases |
| 武田薬品工業株式会社 | 1 cases |
Trends in filing of joint patent applications for the target period (2014 to 2024).
Comparing the number of applications of each company, ノバルティスアーゲー has the highest number of joint applications in the last for the target period (2014 to 2024) with 296 cases, followed by ジェネンテックインコーポレイテッド with 286 cases.
| Name | Cases |
|---|---|
| ノバルティスアーゲー | 296 cases |
| ジェネンテックインコーポレイテッド | 286 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 197 cases |
| ブリストル-マイヤーズスクイブカンパニー | 142 cases |
| エフホフマン-ラロシュアーゲー | 77 cases |
| メルクパテントゲゼルシャフトミットベシュレンクテルハフツング | 58 cases |
| 武田薬品工業株式会社 | 50 cases |
| アメリカ合衆国 | 44 cases |
| 株式会社日立製作所 | 15 cases |
| 株式会社東芝 | 14 cases |
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
Top company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 増殖 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2022 to 2024).
Among the top coapplicants, ジェネンテックインコーポレイテッド has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 14 cases, followed by ザリージェンツオブザユニバーシティオブカリフォルニア with 9 cases.
| Name | Cases |
|---|---|
| ジェネンテックインコーポレイテッド | 14 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 9 cases |
| ブリストル-マイヤーズスクイブカンパニー | 6 cases |
| ノバルティスアーゲー | 4 cases |
| 株式会社東芝 | 1 cases |
| 株式会社日立製作所 | 1 cases |
Trends in filing of joint patent applications for the target period (2014 to 2024).
Among the top coapplicants, ノバルティスアーゲー has the highest number of joint applications in the last for the target period (2014 to 2024) with 296 cases, followed by ジェネンテックインコーポレイテッド with 286 cases.
| Name | Cases |
|---|---|
| ノバルティスアーゲー | 296 cases |
| ジェネンテックインコーポレイテッド | 286 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 197 cases |
| ブリストル-マイヤーズスクイブカンパニー | 142 cases |
| エフホフマン-ラロシュアーゲー | 77 cases |
| 株式会社日立製作所 | 15 cases |
| 株式会社東芝 | 14 cases |
Top company, Change in the Number of JP Patents
Below is a ranking of the number of JP patent applications by 増殖’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by 増殖’s top 7 coapplicants over the last 20 years.
Top company Details (JP)
Trends in filing of joint patent applications with 株式会社東芝
増殖 filed 14 joint applications with 株式会社東芝 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 5 cases in total) is 0.8, and the median is 1.0. The coefficient of variation (standard deviation/mean) is 0.8, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2016 with 4 cases, and their lowest number in 2018 with 0 cases.
| Index | Value |
|---|---|
| Average | 0.8 patents |
| Std Dev | 0.7 |
| COV | 0.8 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 1 cases | 0 |
| 2021 year | 1 cases | -50.0 % |
| 2020 year | 2 cases | +100 % |
Trends in filing of joint patent applications with ノバルティスアーゲー
増殖 filed 296 joint applications with ノバルティスアーゲー for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 101 cases in total) is 16.8, and the median is 14.0. The coefficient of variation (standard deviation/mean) is 0.8, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 62 cases, and their lowest number in 2022 with 4 cases.
| Index | Value |
|---|---|
| Average | 16.8 patents |
| Std Dev | 13.8 |
| COV | 0.8 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 4 cases | -75.0 % |
| 2021 year | 16 cases | +33.3 % |
| 2020 year | 12 cases | -60.0 % |
Trends in filing of joint patent applications with ジェネンテックインコーポレイテッド
増殖 filed 286 joint applications with ジェネンテックインコーポレイテッド for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 87 cases in total) is 14.5, and the median is 16.5. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2014 with 76 cases, and their lowest number in 2022 with 14 cases.
| Index | Value |
|---|---|
| Average | 14.5 patents |
| Std Dev | 6.8 |
| COV | 0.5 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 14 cases | -33.3 % |
| 2021 year | 21 cases | +31.2 % |
| 2020 year | 16 cases | -15.79 % |
Trends in filing of joint patent applications with 株式会社日立製作所
増殖 filed 15 joint applications with 株式会社日立製作所 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 7 cases in total) is 1.2, and the median is 1.0. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2014 with 6 cases, and their lowest number in 2016 with 0 cases.
| Index | Value |
|---|---|
| Average | 1.2 patents |
| Std Dev | 0.7 |
| COV | 0.6 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 1 cases | 0 |
| 2021 year | 1 cases | -50.0 % |
| 2020 year | 2 cases | 0 |
Trends in filing of joint patent applications with ザリージェンツオブザユニバーシティオブカリフォルニア
増殖 filed 197 joint applications with ザリージェンツオブザユニバーシティオブカリフォルニア for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 103 cases in total) is 17.2, and the median is 19.0. The coefficient of variation (standard deviation/mean) is 0.6, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2016 with 31 cases, and their lowest number in 2022 with 9 cases.
| Index | Value |
|---|---|
| Average | 17.2 patents |
| Std Dev | 10.3 |
| COV | 0.6 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 9 cases | -59.1 % |
| 2021 year | 22 cases | +37.5 % |
| 2020 year | 16 cases | -36.0 % |
Information on important patents (JP)
The following shows JP patents held by 増殖 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and 増殖’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which 増殖 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
Glossary
- Cited
- Indicates that the patent/patent application has been cited (by Examiners) in notices of reasons for rejection in the examination process of other (Japanese, U.S., or European) patent applications. The higher the number of citations, the more important the patent/patent application is considered to be.
- Request for invalidation trial
- Indicates that a third party has requested a procedure to invalidate the patent. It is likely to affect the business of third parties and is considered to be of high importance.
- Opposition
- Indicates that a third party has filed a petition with the Patent Office to hear the validity of the patent again. Like the trial for invalidation, it is considered to be of high importance.
- Information provision
- Indicates that a third party has provided the Patent Office with useful information for examination for the patent filed. It is usually considered to be of high importance because it is done to prevent the patent from being granted.
- Browsing request
- Indicates that a third party has requested the Patent Office to view the patent bag (a set of documents exchanged between the Patent Office and the applicant). The bag is often checked prior to trial for invalidation, opposition, and provision of information, and is considered to be a highly important patent.
Invalidationed Trial cases
List of latest Invalidationed Trial patents
In the last 3 years (2021-06-01 ~ 2024-05-31), there were 3 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.0 times. The most recently Invalidation Trial patent is 特許7016341 "ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法" (Invalidation Trial day 2023-03-27) , next is 特許6896700 "ワクチン組成物" (Invalidation Trial day 2023-01-27) .
| - | No. | Title | Invalidation Trial days |
|---|---|---|---|
| 1 | 特許7016341 | ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法 | 2023-03-27 |
| 2 | 特許6896700 | ワクチン組成物 | 2023-01-27 |
| 3 | 特許6987918 | 食肉製品製造方法 | 2022-02-28 |
Top Patents/Patent Applications with the Highest Number of Invalidationed Trial
Of the patent applications filed in the last 10 years (2014-06-01 to 2024-05-31), 5 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.0. The most invalidation trial patent is 特許6987918 "食肉製品製造方法" (1 times) , and the next most invalidation trial patent is 特許6554730 "ビフィドバクテリウム・ロンガム及び海馬ＢＤＮＦ発現" (1 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6987918 | 食肉製品製造方法 | 1 times |
| 2 | 特許6554730 | ビフィドバクテリウム・ロンガム及び海馬ＢＤＮＦ発現 | 1 times |
| 3 | 特許6896700 | ワクチン組成物 | 1 times |
| 4 | 特許7016341 | ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法 | 1 times |
| 5 | 特許6035372 | 肺癌治療剤 | 1 times |
Oppositioned cases
List of latest Oppositioned patents
In the last 3 years (2021-06-01 ~ 2024-05-31), there were 18 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7328390 "フィブロイン様タンパク質の製造法" (Opposition day 2024-02-15) , next is 特許7298844 "細胞培養物の製造方法" (Opposition day 2023-12-26) .
| - | No. | Title | Opposition days |
|---|---|---|---|
| 1 | 特許7328390 | フィブロイン様タンパク質の製造法 | 2024-02-15 |
| 2 | 特許7298844 | 細胞培養物の製造方法 | 2023-12-26 |
| 3 | 特許7291217 | 足場非依存性細胞およびその使用 | 2023-12-14 |
| 4 | 特許7308329 | ＧＡＢＡを有効成分とするサルコペニア予防または改善剤 | 2023-10-26 |
| 5 | 特許7262385 | 心筋細胞の成熟 | 2023-10-18 |
| 6 | 特許7249627 | ヒーターユニット、排水管、および排水システム | 2023-10-02 |
| 7 | 特許7241953 | 代替肉製品 | 2023-09-14 |
| 8 | 特許7168454 | 固体表面のスパイダーシルクコーティング | 2023-05-08 |
| 9 | 特許7075521 | 注射器 | 2022-11-25 |
| 10 | 特許7042954 | 注射器 | 2022-09-28 |
Protested cases
List of latest Protested patents
In the last 3 years (2021-06-01 ~ 2024-05-31), there were 59 patents Protest from third parties. The average number of Protest is 1.4 times. The most recently Protest patent is 特開2023-062563 "栄養組成物" (Protest day 2024-03-19) , next is 特表2023-534047 "オリゴ糖組成物及び使用方法" (Protest day 2024-02-07) .
| - | No. | Title | Protest days |
|---|---|---|---|
| 1 | 特開2023-062563 | 栄養組成物 | 2024-03-19 |
| 2 | 特表2023-534047 | オリゴ糖組成物及び使用方法 | 2024-02-07 |
| 3 | 特表2023-544184 | 接着細胞からのウイルスのバイオリアクター生成 | 2024-02-01 |
| 4 | 特開2023-052609 | 細胞培養物の製造方法 | 2024-01-23 |
| 5 | 特開2021-095350 | 繊維芽細胞増殖促進用組成物、皮膚コラーゲン産生促進用組成物、皮膚ヒアルロン酸産生促進用組成物、皮膚エラスチン産生促進用組成物、及び保湿性の改善用組成物 | 2024-01-17 |
| 6 | 特開2022-049288 | ビフィズス菌増殖促進効果のある食品素材 | 2024-01-16 |
| 7 | 特表2021-500373 | 線維芽細胞活性化タンパク質α（ＦＡＰ−α）を標的とする撮像剤および放射線療法用薬剤 | 2024-01-12 |
| 8 | 特開2023-161047 | 育毛促進用組成物 | 2023-12-20 |
| 9 | 特開2022-080035 | ブラウティア属細菌増殖促進用組成物 | 2023-11-15 |
| 10 | 特開2021-162323 | 疾患鑑別支援方法、疾患鑑別支援装置、及び疾患鑑別支援コンピュータプログラム | 2023-09-01 |
| 11 | 特開2023-079170 | 抗ウイルス組成物、抗ウイルス保護フィルムおよびその製造方法 | 2023-08-18 |
| 12 | 特許7471069 | 移植片の活性を高める方法 | 2023-08-09 |
| 13 | 特開2023-052414 | 免疫機能を調節するため及び腸の炎症を治療するためのベータ－１，３－グルカンの使用 | 2023-07-26 |
| 14 | 特表2021-522805 | ｈＭＰＣの集団をゼノフリー生成するための方法 | 2023-07-25 |
| 15 | 特開2022-072243 | 腸内細菌叢改善用組成物及び腸内腐敗物質産生抑制用組成物 | 2023-07-19 |
| 16 | 特開2023-049333 | 育毛剤及び毛乳頭細胞増殖促進剤 | 2023-07-04 |
| 17 | 特開2023-017035 | 歯周組織再生剤、歯周組織再生方法、歯周組織増殖・活性化剤及び歯周組織アンチエージング剤 | 2023-06-26 |
| 18 | 特開2021-169414 | 歯肉組織内部の歯周病菌に対する歯周病菌抑制剤 | 2023-05-10 |
| 19 | 特開2021-126061 | 新規乳酸菌用培地 | 2023-04-20 |
| 20 | 特許7328390 | フィブロイン様タンパク質の製造法 | 2023-03-24 |
Top Patents/Patent Applications with the Highest Number of Protested
Of the patent applications filed in the last 10 years (2014-06-01 to 2024-05-31), 101 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.4. The most protest patent is 特許7101362 "１，２－ジヒドロキシ－５－（メチルスルフィニル）ペンタン－３－オンの生成能が低い酵母の作出方法" (6 times) , and the next most protest patent is 特許6384861 "ハロモナス菌を用いた３−ヒドロキシ酪酸の製造方法" (4 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許7101362 | １，２－ジヒドロキシ－５－（メチルスルフィニル）ペンタン－３－オンの生成能が低い酵母の作出方法 | 6 times |
| 2 | 特許6384861 | ハロモナス菌を用いた３−ヒドロキシ酪酸の製造方法 | 4 times |
| 3 | 特許7407509 | 外用組成物 | 4 times |
| 4 | 特開2020-019713 | 歯ぐき細胞増殖促進剤 | 4 times |
| 5 | 特許7290906 | 歯根膜再生剤及びその製造方法 | 3 times |
Inspectioned cases
List of latest Inspectioned patents
In the last 3 years (2021-06-01 ~ 2024-05-31), there were 347 patents Inspection from third parties. The average number of Inspection is 1.3 times. The most recently Inspection patent is 特表2022-501338 "抗腫瘍剤としてのキナゾリン誘導体" (Inspection day 2024-04-05) , next is 特開2022-065089 "ジフテリア毒素－インターロイキン－３コンジュゲートに基づく方法及び組成物" (Inspection day 2024-04-01) .
| - | No. | Title | Inspection days |
|---|---|---|---|
| 1 | 特表2022-501338 | 抗腫瘍剤としてのキナゾリン誘導体 | 2024-04-05 |
| 2 | 特開2022-065089 | ジフテリア毒素－インターロイキン－３コンジュゲートに基づく方法及び組成物 | 2024-04-01 |
| 3 | 特許5185443 | 生体組織から分離できる多能性幹細胞画分 | 2024-03-29 |
| 4 | 特開2022-110097 | 支持細胞を用いない赤血球の生産方法 | 2024-03-29 |
| 5 | 特表2023-532569 | 抗腫瘍壊死因子受容体抗体（抗ＴＮＦＲ２抗体）及びその使用 | 2024-03-28 |
| 6 | 特許5752671 | ＶＥＧＦアンタゴニスト製剤 | 2024-03-28 |
| 7 | 特表2023-527884 | 異常な血管新生を治療するための局所眼科用組成物および方法 | 2024-03-28 |
| 8 | 特許5376573 | ＶＥＧＦアンタゴニスト製剤 | 2024-03-28 |
| 9 | 特表2021-505168 | 操作されたＴ細胞の組成物を製造するための方法 | 2024-03-26 |
| 10 | 特開2023-062563 | 栄養組成物 | 2024-03-26 |
| 11 | 特開2022-104994 | 細胞培養のための細胞外マトリクス組成物ビーズ | 2024-03-26 |
| 12 | 特開2019-011372 | インターロイキン−６関連疾患の治療方法 | 2024-03-26 |
| 13 | 特許7433800 | 麹菌の液体組織培養物の製造および利用方法 | 2024-03-25 |
| 14 | 特表2021-516049 | 組換えＴ細胞受容体遺伝子を用いて細胞ベースの治療薬を製造するための技法 | 2024-03-19 |
| 15 | 特表2023-525436 | ビグアニド系化合物、及びフラボン、ヒドロキシフラボン、フラバノン、フラボン誘導体、ヒドロキシフラボン誘導体、フラバノン誘導体の複合剤を有効成分として含有する癌の予防または治療用薬学的組成物 | 2024-03-18 |
| 16 | 特表2023-528059 | 抗ウイルス剤及び抗うつ剤を有効成分として含有する癌の予防または治療用薬学的組成物 | 2024-03-18 |
| 17 | 特表2021-529821 | イムノグロブリンを除去又は減少させるための遺伝子治療ベクターの形質導入を増加または増強するための組成物および方法 | 2024-03-13 |
| 18 | 特表2021-531038 | ストレス顆粒集合を調節するためのシステム及び方法 | 2024-02-20 |
| 19 | 特表2020-524139 | 骨髄増殖性腫瘍関連骨髄線維症及び貧血を治療するための方法 | 2024-02-16 |
| 20 | 特表2022-516496 | キメラ受容体ポリペプチド及びその使用 | 2024-02-14 |
Top Patents/Patent Applications with the Highest Number of Inspectioned
Of the patent applications filed in the last 10 years (2014-06-01 to 2024-05-31), 672 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.3. The most inspection patent is 特開2015-016345 "新アルカリ性電子エナジー" (19 times) , and the next most inspection patent is 特許7433800 "麹菌の液体組織培養物の製造および利用方法" (13 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特開2015-016345 | 新アルカリ性電子エナジー | 19 times |
| 2 | 特許7433800 | 麹菌の液体組織培養物の製造および利用方法 | 13 times |
| 3 | 特開2016-144451 | より新規形態の干渉ＲＮＡ分子 | 7 times |
| 4 | 特許6402368 | 真核生物細胞を改変する方法 | 6 times |
| 5 | 特開2019-011372 | インターロイキン−６関連疾患の治療方法 | 6 times |
Cited cases
Top Patents/Patent Applications with the Highest Number of Cited
Of the patent applications filed in the last 10 years (2014-06-01 to 2024-05-31), 2,973 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.2. The most cited patent is 特許6521977 "免疫調節剤としての１，２，４−オキサジアゾール誘導体" (39 times) , and the next most cited patent is 特許6559123 "ＫＲＡＳＧ１２Ｃの阻害剤" (31 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6521977 | 免疫調節剤としての１，２，４−オキサジアゾール誘導体 | 39 times |
| 2 | 特許6559123 | ＫＲＡＳＧ１２Ｃの阻害剤 | 31 times |
| 3 | 特許6778114 | イミド系タンパク質分解モジュレーター及び関連する使用方法 | 29 times |
| 4 | 特許6491202 | サイクリン依存性キナーゼ７（ＣＤＫ７）の多環阻害剤 | 26 times |
| 5 | 特表2018-517454 | 非血管狭窄のための薬物コーティングされたバルーンカテーテル | 25 times |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
Please note the following points for use.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
Citation of patent application status and ranking information
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Graphs are image data.
Please note that the various graphs are image data, but we cannot provide them in text data.Scope of coverage for each goal/target
- Based on the description of each goal and target of the SDGs, we have set the scope of technologies to be covered based on our and e-Patent's past experience, etc. (in some cases, the search is based on social issues themselves). Therefore, please note that there is a possibility that this "SDGs Global Company Ranking from Patent Perspective" may not cover 100%.
- A population search formula is clearly indicated for each goal/target (database: Patent Integration). You may use the population search formula as it is, or you may improve it by yourself.
- This search covers patents and utility models, including both published and registered patents (design and design patents are excluded). The unit of count is the number of applications, not the number of patent families.
About the name collation and name control of applicants and right holders
- Company rankings are based on the results calculated by "Patent Integration", with Japanese organizations in Japanese and other companies in English (some are in Japanese).
- Company names may be the names of the companies at the time of application, but the results calculated by Patent Integration are used as is. Company names are used as they were at the time of application.
- Because of the fluctuation in the names of companies (i.e., applicant/right holder names in the patent information), there are cases where the same company appears more than once in the top 10. The number of applications filed by the same company in the top 10 is the total number of applications filed by the company.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.